| |
|
|
|
|
|
|
|||
|
BRIEF REPORT
From the Wolf Szmuness Laboratory of Epidemiology, the
F. H. Allen Laboratory of Immunogenetics, and the Laboratory of
Hematopoietic Progenitors of the New York Blood Center, New York, NY;
the Department of Obstetrics and Gynecology, Brooklyn Hospital Medical
Center, Brooklyn, NY; Heinreich Heine University, Dusseldorf, Germany;
and Duke University Medical Center, Durham, NC.
Placental/umbilical cord blood (PCB) is a source of hematopoietic
stem cells for bone marrow reconstitution. Engraftment speed and
survival are related to the total nucleated cell (TNC) dose of the
graft. This study explored the possible influence on engraftment of
nucleated red blood cells (NRBCs) in the graft. Automated hematology analyzers were used to enumerate TNCs. NRBCs were counted by visual examination or by using an automated analyzer. Hematopoietic progenitor cells were enumerated as either colony-forming cells or
CD34+ cells. Transplant centers reported on transplant
outcome in 1112 patients given PCB grafts through September 2001. NRBCs
correlated with progenitor cell numbers. Both white blood cell and NRBC
dose were independently predictive of myeloid engraftment speed.
Because NRBC dose predicted engraftment speed, inclusion of NRBCs in
the TNC count does not reduce the effectiveness of the prefreezing TNC
count as an index of the quality of a PCB unit as a graft. The
correlation between the number of NRBCs and the number of hematopoietic
progenitor cells probably reflects the involvement of early stem cells
in erythroid responses. This article has been cited by other articles:
| |||||||||||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||